HK1131339A1 - Prophylactic or therapeutic agent for viral disease - Google Patents

Prophylactic or therapeutic agent for viral disease

Info

Publication number
HK1131339A1
HK1131339A1 HK09109781.5A HK09109781A HK1131339A1 HK 1131339 A1 HK1131339 A1 HK 1131339A1 HK 09109781 A HK09109781 A HK 09109781A HK 1131339 A1 HK1131339 A1 HK 1131339A1
Authority
HK
Hong Kong
Prior art keywords
prophylactic
therapeutic agent
viral disease
viral
disease
Prior art date
Application number
HK09109781.5A
Other languages
English (en)
Original Assignee
Meiji Seika Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Pharma Co Ltd filed Critical Meiji Seika Pharma Co Ltd
Publication of HK1131339A1 publication Critical patent/HK1131339A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK09109781.5A 2006-07-07 2009-10-22 Prophylactic or therapeutic agent for viral disease HK1131339A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006187943 2006-07-07
PCT/JP2007/063545 WO2008004653A1 (fr) 2006-07-07 2007-07-06 Agent prophylactique ou thérapeutique pour une maladie virale

Publications (1)

Publication Number Publication Date
HK1131339A1 true HK1131339A1 (en) 2010-01-22

Family

ID=38894619

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09109781.5A HK1131339A1 (en) 2006-07-07 2009-10-22 Prophylactic or therapeutic agent for viral disease

Country Status (15)

Country Link
US (1) US8277793B2 (fr)
EP (1) EP2050459B1 (fr)
JP (1) JP5114401B2 (fr)
KR (1) KR20090031871A (fr)
CN (1) CN101489579B (fr)
AU (1) AU2007270386A1 (fr)
BR (1) BRPI0713278A2 (fr)
CA (1) CA2656959A1 (fr)
ES (1) ES2402589T3 (fr)
HK (1) HK1131339A1 (fr)
MX (1) MX2008016166A (fr)
RU (1) RU2433827C2 (fr)
UA (1) UA95299C2 (fr)
WO (1) WO2008004653A1 (fr)
ZA (1) ZA200900035B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102470162A (zh) * 2009-06-30 2012-05-23 明治制果药业株式会社 用于治疗难治性c型慢性肝炎的药剂以及方法
TW201143759A (en) * 2009-12-15 2011-12-16 Meiji Seika Kaisha Triterpene derivative, and prophylactic or therapeutic agent for chronic hepatitis c
WO2011074608A1 (fr) * 2009-12-15 2011-06-23 明治製菓株式会社 Agent prophylactique ou thérapeutique pour le traitement de l'hépatite c chronique
EP2937401B8 (fr) * 2014-04-22 2017-08-02 Merck Patent GmbH Milieu cristallin liquide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444063A (en) 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
CN1220698C (zh) 1995-07-07 2005-09-28 明治制果株式会社 三萜衍生物及治疗肝脏疾病的药物
EP1326594A2 (fr) * 2000-10-18 2003-07-16 Schering Corporation Polytherapie a base de ribavirine et d'interferon alpha pegyle contre le virus de l'hepatite c
JP2005035913A (ja) 2003-07-18 2005-02-10 Toray Ind Inc プラス鎖ｒｎａを遺伝情報に持つウイルスに対する治療剤
WO2005097815A1 (fr) 2004-03-30 2005-10-20 Meiji Seika Kaisha, Ltd. Processus de production de saponine de groupe b

Also Published As

Publication number Publication date
EP2050459A4 (fr) 2011-05-11
UA95299C2 (ru) 2011-07-25
MX2008016166A (es) 2009-02-25
RU2009104066A (ru) 2010-08-20
US20090324541A1 (en) 2009-12-31
JP5114401B2 (ja) 2013-01-09
RU2433827C2 (ru) 2011-11-20
AU2007270386A1 (en) 2008-01-10
US8277793B2 (en) 2012-10-02
EP2050459B1 (fr) 2013-03-13
BRPI0713278A2 (pt) 2012-03-06
CN101489579A (zh) 2009-07-22
KR20090031871A (ko) 2009-03-30
JPWO2008004653A1 (ja) 2009-12-03
CN101489579B (zh) 2012-08-15
ES2402589T3 (es) 2013-05-07
CA2656959A1 (fr) 2008-01-10
WO2008004653A1 (fr) 2008-01-10
EP2050459A1 (fr) 2009-04-22
ZA200900035B (en) 2010-03-31

Similar Documents

Publication Publication Date Title
GB0609492D0 (en) Therapeutic agents
GB0608928D0 (en) Therapeutic agents
GB0601962D0 (en) Therapeutic agents
HUE054365T2 (hu) Bór-ftalidok terápiás alkalmazásra
ZA200804918B (en) Therapeutic vaccine
EP1864971A4 (fr) Agent prophylactique/therapeutique pour le diabete
GB0621452D0 (en) Therapy for liver disease
GB0521139D0 (en) Therapeutic agent
IL197389A0 (en) Prophylactic or therapeutic agent for cancer
GB0516091D0 (en) Therapeutic agent
GB0616214D0 (en) Therapeutic Agents
IL193597A0 (en) Conjunctival tissue system
EP2133083A4 (fr) Agent thérapeutique pour une maladie infectieuse cutanée ou des muqueuses
GB0611152D0 (en) Therapeutic agents
EP1968603A4 (fr) Composes therapeutiques amine-arylsulfonamide conjugues
GB0620818D0 (en) Therapeutic agents
GB0906964D0 (en) Eyewash system
EP2018873A4 (fr) Agent prophylactique/therapeutique pour le cancer
GB0620059D0 (en) Therapeutic agents
EP1953164A4 (fr) Agent thérapeutique ou prophylactique pour un trouble fonctionnel de l'intestin
GB0609676D0 (en) Therapeutic agents
HK1131339A1 (en) Prophylactic or therapeutic agent for viral disease
HK1138204A1 (en) Prophylactic or therapeutic agent for alopecia
EP2140876A4 (fr) Agent thérapeutique comprenant de la vasohibine
EP1859795A4 (fr) Agent therapeutique pour les maladies ophtalmiques

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160706